Available to SourceHuman Prescription DrugNeurological & Psychiatric

Pristiq (Desvenlafaxine Succinate)

25 mg/1 · Extended-Release Tablet

By Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.

Desvenlafaxine Succinate · Extended-Release Tablet · 25 mg

NDC: 0008-1210
Route: Oral
Therapeutic class: Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
Marketing category: NDA

Package sizes

30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1210-30)NDC 0008-1210-30Available to Order

Request This Medication

*Expect a reply within 2 business hours with availability and pricing.

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request a quote

Request this medication.

Pick the package size you need and we’ll respond with availability, lot details, dating, and pricing within 2 business hours. Mark it as Rush or Emergency if you need it faster.

DSCSA-compliant pedigree on every order
Cold-chain capable where applicable
Same-day fulfillment available for urgent needs

Related in Neurological & Psychiatric

See all →

Pristiq (Desvenlafaxine Succinate)

Package sizes

Additional information

Request this medication.

Related in Neurological & Psychiatric

Guna-Mood

Neuro Links

Allergy Rescue

New Stock Fungi Mix